Phase I Clinical Trial to Evaluate the Safety, Tolerance, and Exploratory Efficacy of ADSTEM Inj. in Patients With Moderate to Severe, Subacute and Chronic Atopic Dermatitis
Phase of Trial: Phase I
Latest Information Update: 28 Dec 2017
At a glance
- Drugs Autologous stem cell therapy (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions
- Sponsors EHL Bio
- 20 Dec 2017 Status changed from active, no longer recruiting to completed.
- 17 Aug 2017 Planned End Date changed from 1 Nov 2017 to 1 Dec 2017.
- 17 Aug 2017 Planned primary completion date changed from 1 Nov 2017 to 1 Dec 2017.